2. UroToday Home
  3. Video Lectures

Precision Medicine in Prostate Cancer

Precision Medicine in Prostate Cancer
Clinical Understanding of PARP Inhibitors in Prostate Cancer - Elena Castro, Wassim Abida, and Karen Knudson
June 2, 2020
Details
Precision Medicine in Prostate Cancer
Best of ASCO 2020 Prostate Cancer - Oliver Sartor
May 31, 2020
Details
Precision Medicine in Prostate Cancer
TheraP: 177Lu-PSMA617 Theranostic vs Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer (mCRPC) - Michael Hofman & Ian Davis
May 29, 2020
Details
Precision Medicine in Prostate Cancer
PARP Inhibition in Castration-resistant Prostate Cancer - Daniel Petrylak
May 24, 2020
Details
Precision Medicine in Prostate Cancer
PARP Inhibitors Changing the Standard of Care for Treatment of Metastatic Prostate Cancer (mCRPC) - The PROfound Study
May 9, 2020
Details
Precision Medicine in Prostate Cancer
TheraP Trial Design Evaluating 177Lu‐PSMA‐617 Theranostic Treatment vs Cabazitaxel in Progressive Metastatic Castration‐Resistant Prostate Cancer - Michael Hofman
May 8, 2020
Details
Precision Medicine in Prostate Cancer
Genetically Informed Treatment for Advanced and Metastatic Prostate Cancer - Alicia Morgans
April 6, 2020
Details
Precision Medicine in Prostate Cancer
Targeted Molecular Therapies for Treatment of Advanced Prostate Cancer - Scott Tagawa
March 30, 2020
Details
Precision Medicine in Prostate Cancer
Imaging and Flare Responses When Assessing Patients with Metastatic Castration-Resistant Prostate Cancer - Anwar Padhani
September 26, 2019
Details
Precision Medicine in Prostate Cancer
High Activity Pain Reduction and Low Toxicity with Lu177 PSMA617 Theranostics - Michael Hofman
December 27, 2019
Details
Precision Medicine in Prostate Cancer
The VISION Trial: Radionuclide Therapy Plus Standard Therapy for Metastatic Castration Resistant Prostate Cancer - Oliver Sartor and Michael Morris
November 18, 2019
Details
Precision Medicine in Prostate Cancer
177LU-PSMA-617 in the Treatment of Patients with Progressive PSMA-Positive Metastatic Castration-Resistant Prostate Cancer - Oliver Sartor
October 31, 2019
Details
Precision Medicine in Prostate Cancer
A Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer - The VISION Trial, Interview with Oliver Sartor
October 14, 2019
Details
Precision Medicine in Prostate Cancer
PROfound Study - PARP-inhibitor Olaparib in Advanced Prostate Cancer Patients with Specific Tumor Mutations - Maha Hussain
October 10, 2019
Details
Precision Medicine in Prostate Cancer
PSMA Targeted Therapies Presentation - Michael Hofman
September 18, 2019
Details
Precision Medicine in Prostate Cancer
Theranostic Approaches for Advanced Prostate Cancer - Michael Hofman
February 25, 2019
Details
Precision Medicine in Prostate Cancer
State of the Art: Treatment Update in Prostate Cancer- Oliver Sartor
November 2, 2018
Details
Precision Medicine in Prostate Cancer
PSMA Imaging and Theranostics: Future Impact to Patient Management– Robert Flavell
August 15, 2018
Details